This is a non-core endpoint: only basic statistics are computed.
Superficial injury of ankle and foot, unspecified
ST19_SUPERF_INJURY_ANKLE_FOOT_UNSPE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
185 |
4. Check minimum number of eventsNone |
185 |
5. Include endpointsNone |
185 |
6. Filter based on genotype QC (FinnGen only) |
185 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_ANKLE_FOOT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S90
- Name in latin
- Laesio superficialis tarsi/pedis non specificata
Similar endpoints
↥List of similar endpoints to
Superficial injury of ankle and foot, unspecified
based on the number of shared cases.
Similar with more cases:
- Superficial injury of ankle and foot
- Injuries to the ankle and foot
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 185 | 115 | 70 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | 39.64 | 37.85 | 42.57 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 168
- Matched controls
- 1680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S90.9
ICD-10 Finland
Superficial injury of ankle and foot, unspecified
+∞
238.8
168
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
11.0
18.9
37
42
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.8
17.7
72
225
W22
ICD-10 Finland
Striking against or struck by other object(s)
9.0
13.6
29
38
X59
ICD-10 Finland
Exposure to unspecified factor
3.9
10.9
50
164
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
7.7
10.0
23
34
N02AX02
ATC
tramadol; systemic, rectal
2.7
8.3
72
360
S92.3
ICD-10 Finland
Fracture of metatarsal bone
23.4
8.1
11
5
S93.4
ICD-10 Finland
Sprain and strain of ankle
5.3
7.7
23
49
X58
ICD-10 Finland
Exposure to other specified factors
3.4
7.0
34
115
J01DB01
ATC
cefalexin; oral
2.9
6.4
145
1145
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
9.8
6.4
12
13
M25.5
ICD-10 Finland
Pain in joint
2.5
6.3
56
276
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40758558) Short blood count panel - Blood
64
369
2.12
5.27
5.4
7.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
34
162
2.35
4.38
1.9
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
18
62
3.11
4.31
1.2
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
34
167
2.27
4.08
1.7
2.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
51
304
1.94
3.67
5.9
4.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
76
519
1.79
3.55
5.1
4.8
g/l
35.8
36.5
0.50
71
494
(42870588) Differential panel, method unspecified - Blood
71
485
1.75
3.26
5.8
5.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
121
2.23
3.10
2.5
2.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
25
121
2.23
3.10
2.5
2.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
99
749
1.69
3.09
7.4
5.9
%
29.2
29.2
0.01
90
716
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
209
1.96
3.08
3.6
2.8
ng/l
67.8
347.2
1.02
24
140
(3028300) Cannabinoids [Presence] in Urine
25
122
2.21
3.04
2.5
2.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
77
2.48
2.92
1.4
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
75
533
1.68
2.92
6.5
6.8
mmol/l
1.2
1.2
0.55
69
489
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
65
445
1.71
2.90
3.2
2.9
ng/l
20.2
29.6
0.64
37
255
(3018010) Neutrophils/100 leukocytes in Blood
97
739
1.66
2.88
6.5
5.7
%
56.8
56.6
0.05
89
704
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
39
230
1.88
2.86
1.6
1.3
u/ml
12.0
8.8
0.11
13
94
(3037522) Nuclear Ab [Titer] in Serum
33
184
1.97
2.85
1.5
1.4
titre
617.1
535.4
—
7
39
(3037467) Urinalysis macro (dipstick) panel - Urine
124
1009
1.69
2.83
3.7
4.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
24
121
2.13
2.70
2.6
2.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
94
721
1.62
2.65
7.7
6.3
%
7.6
8.3
1.04
88
687
(3006504) Eosinophils/100 leukocytes in Blood
93
718
1.59
2.51
7.4
6.0
%
2.7
2.8
0.25
87
673
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
39
240
1.79
2.49
1.5
1.2
iu/ml
15.2
30.1
0.91
11
77
(3016879) Cocaine [Presence] in Urine
22
112
2.09
2.42
2.7
2.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
12
5.13
2.42
1.0
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
17
78
2.30
2.39
2.5
4.1
mmol/l
1.2
1.7
—
10
60
(3045424) Erythrocytes [Presence] in Urine
8
23
3.59
2.30
1.0
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
65
469
1.59
2.29
2.1
1.8
pmol/l
94.4
94.1
0.02
38
227
(3019198) Lymphocytes [#/volume] in Blood
99
791
1.54
2.20
6.7
6.0
e9/l
2.2
1.9
2.35
89
718
(3001604) Monocytes [#/volume] in Blood
95
755
1.53
2.15
6.7
6.1
e9/l
0.6
0.6
0.92
84
675
(3032080) INR in Blood by Coagulation assay
62
448
1.58
2.15
6.2
6.7
inr
1.2
1.2
0.17
26
155
(3006315) Basophils [#/volume] in Blood
95
757
1.52
2.11
6.8
6.1
e9/l
0.0
0.0
1.30
85
674
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
126
1068
1.56
2.10
7.5
6.7
u/l
75.9
75.0
0.12
118
997
(3013707) Erythrocyte sedimentation rate by Westergren method
127
1080
1.56
2.07
6.0
3.6
mm/h
12.6
9.6
0.93
120
989
(3015377) Calcium [Moles/volume] in Serum or Plasma
58
419
1.56
2.00
2.3
3.2
mmol/l
2.3
2.4
0.33
52
369
(3011288) Drugs identified in Urine by Screen method
17
85
2.10
1.97
3.9
3.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
33
2.81
1.96
1.3
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
17
86
2.08
1.92
2.3
3.9
ng/l
86.3
71.9
0.18
17
78
(3022096) Basophils/100 leukocytes in Blood
87
691
1.49
1.91
7.8
6.1
%
0.8
0.7
0.67
80
648
(3022313) Gas panel - Capillary blood
13
59
2.29
1.89
2.2
4.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
54
389
1.55
1.87
2.3
2.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
29
178
1.75
1.87
1.1
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
40
2.59
1.87
1.6
2.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
45
311
1.59
1.86
2.2
2.4
umol/l
331.7
2474.4
0.78
36
275
(3021960) Folate [Moles/volume] in Serum or Plasma
41
277
1.62
1.86
1.7
1.5
nmol/l
18.4
20.5
0.42
35
241
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
24
2.99
1.74
1.6
2.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
7
24
2.99
1.74
2.0
5.0
kpa
4.9
5.1
—
7
24
(3027315) Oxygen [Partial pressure] in Blood
7
24
2.99
1.74
2.0
5.0
kpa
9.1
9.6
—
7
24
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
24
2.99
1.74
1.0
1.5
e6/l
1532.4
262.0
—
7
18
(3022621) pH of Urine by Test strip
17
90
1.98
1.71
2.4
2.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
41
283
1.58
1.70
2.2
2.5
e6/l
5.8
5.6
0.05
33
253
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
15
76
2.06
1.70
6.4
8.8
mmol/l
25.5
25.1
0.13
15
76
(3013650) Neutrophils [#/volume] in Blood by Automated count
105
879
1.45
1.69
8.6
9.3
e9/l
4.2
4.0
0.41
98
777
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
142
1262
1.54
1.68
3.6
3.6
—
—
—
0
0
(4094501)
6
19
3.23
1.67
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
57
2.18
1.59
1.6
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
64
2.11
1.58
2.7
2.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
95
789
1.42
1.55
7.0
6.3
e9/l
0.2
0.2
0.33
88
709
(3018418) pH of Serum or Plasma
50
371
1.48
1.49
3.2
3.4
ph
7.4
7.4
—
10
74
(3021589) Normoblasts [#/volume] in Blood
83
678
1.41
1.47
9.2
8.9
e9/l
0.0
0.0
0.26
70
553
(3002582) Erythrocytes [#/volume] in Urine
54
408
1.46
1.47
2.9
3.0
e6/l
19.8
55.8
1.47
44
315
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
43
315
1.48
1.36
1.8
1.9
mg/l
0.9
0.9
0.02
28
238
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
57
442
1.42
1.34
2.2
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
43
317
1.46
1.32
3.3
2.0
mg/l
3.0
2.8
0.12
36
272
(3021901) Oxygen saturation in Capillary blood
6
24
2.55
1.31
1.0
2.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
197
1.56
1.29
2.4
2.8
e6/l
1.2
3.4
1.97
19
105
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
77
1.89
1.29
1.4
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
18
2.82
1.29
1.2
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
62
492
1.39
1.27
3.4
3.5
e6/l
32.6
95.3
0.75
44
335
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
74
606
1.37
1.25
6.7
7.4
mmol/l
1.2
1.2
0.63
65
511
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
30
208
1.53
1.23
2.6
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
16
94
1.77
1.22
9.2
10.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
44
331
1.43
1.21
3.4
3.3
kg/l
1.0
1.0
—
9
37
(3052851) Hemolysis interference index of Serum or Plasma
8
38
2.15
1.20
3.0
2.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
157
1458
1.51
1.19
17.2
12.3
mmol/l
139.4
139.7
0.90
151
1414
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
39
2.10
1.17
2.0
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
157
1460
1.50
1.16
17.2
12.3
mmol/l
3.9
3.9
0.09
151
1411
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
58
1.95
1.14
1.8
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
96
1.73
1.14
2.6
2.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
14
81
1.79
1.12
1.1
1.1
—
—
—
0
0
(4010399)
16
97
1.71
1.11
1.4
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
21
2.42
1.09
1.0
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
36
266
1.44
1.09
2.7
2.8
mosm/kgh2o
521.8
570.4
0.69
31
229
(3021601) Nitrite [Presence] in Urine by Test strip
86
733
1.32
1.08
4.0
4.8
estimate
0.0
0.0
0.00
21
144
(3044889) 12 lead EKG panel
105
922
1.32
1.07
2.9
3.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
75
1.79
1.06
1.6
3.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
87
745
1.32
1.05
3.0
3.4
estimate
0.0
0.0
0.00
20
139
(3024928) Oxygen saturation in Venous blood
5
22
2.31
1.04
1.2
4.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
9
47
1.96
1.04
2.9
3.3
%
157.9
174.4
—
9
47
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
165
1.52
1.03
2.4
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
13
76
1.76
1.02
1.3
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
116
1.61
1.01
3.9
2.5
u/l
2673.4
5037.5
—
10
49
(3050129) First trimester maternal screen panel - Serum or Plasma
6
116
0.50
0.98
1.2
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
42
326
1.37
0.97
5.2
4.0
%
90.8
94.5
0.37
42
321
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
37
1.93
0.95
1.0
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
57
466
1.32
0.94
3.4
3.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
52
1.77
0.94
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
52
1.77
0.94
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
52
1.77
0.94
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
48
385
1.33
0.90
3.1
3.5
estimate
0.0
0.0
0.00
20
139
(3019309) Folate [Moles/volume] in Red Blood Cells
26
188
1.45
0.89
2.1
1.6
nmol/l
1356.1
1180.9
0.45
21
144
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
31
232
1.40
0.89
2.2
1.6
pmol/l
260000351.4
31905207.1
0.41
25
210
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
43
1.90
0.88
1.5
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
11
64
1.76
0.88
2.0
2.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
46
368
1.33
0.88
2.8
2.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
30
2.03
0.87
1.2
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
85
742
1.27
0.84
3.0
3.3
estimate
0.0
0.0
0.00
19
143
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
160
1515
1.42
0.84
17.2
11.3
mg/l
22.6
20.5
0.34
134
1160
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
46
1.77
0.83
1.6
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
53
438
1.29
0.81
3.1
2.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
90
1.60
0.81
1.2
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
24
0.00
0.80
0.0
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
24
0.00
0.80
0.0
1.0
—
28.0
—
0
6
(3030467) Casts [#/volume] in Urine by Automated count
46
374
1.31
0.79
2.9
3.0
e6/l
0.2
0.3
0.54
36
287
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
195
0.64
0.77
2.2
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
68
584
1.26
0.76
2.9
3.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
36
285
1.33
0.74
3.3
2.8
ng/l
1004.5
1103.3
0.11
30
223
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
76
663
1.25
0.74
4.9
4.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
227
0.68
0.74
1.4
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
25
2.03
0.73
1.6
5.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
27
1.87
0.69
1.6
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
28
216
1.35
0.68
2.2
2.6
e6/l
0.3
1.0
3.05
18
123
(40768443) Skin Pathology biopsy report
7
43
1.65
0.67
1.0
1.1
—
—
—
0
0
(3012544) pH of Venous blood
17
120
1.46
0.67
3.4
5.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
124
1150
1.24
0.66
5.5
3.8
pmol/l
14.4
14.6
0.39
118
1051
(3019225) pH of Specimen
15
104
1.48
0.65
3.5
4.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
29
1.74
0.64
1.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
113
1.46
0.63
1.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
151
1435
1.28
0.62
4.0
4.0
mmol/l
2.8
2.8
0.04
138
1332
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
21
158
1.37
0.60
1.3
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
35
285
1.28
0.60
1.4
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
3.5
—
16.6
—
0
22
(3000492) Spirometry study
20
150
1.37
0.59
1.2
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
35
1.74
0.58
1.2
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
54
1.50
0.58
1.1
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
59
1.55
0.56
2.2
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
41
344
1.25
0.55
1.9
2.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
144
1367
1.24
0.55
14.3
9.9
ml/min/173m2
89.7
90.1
0.06
124
1092
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
9
62
1.47
0.54
1.7
2.0
nmol/l
31.3
35.9
—
9
62
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
117
1091
1.20
0.53
3.4
2.8
u/l
37.5
39.8
0.26
112
1041
(3003327) Ova and parasites identified in Stool by Light microscopy
9
63
1.45
0.53
1.3
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
39
328
1.24
0.52
2.5
3.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
30
245
1.27
0.51
3.9
1.9
ug/g
113.2
117.8
0.04
25
189
(4035726)
7
106
0.65
0.50
1.3
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
62
549
1.19
0.50
2.0
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
51
444
1.21
0.49
2.6
2.9
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
7
46
1.54
0.49
1.3
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
13
94
1.41
0.47
1.3
1.2
u/ml
121.7
209.9
0.48
13
85
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
50
1.42
0.45
1.1
1.0
—
12.8
—
0
7
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
95
1.40
0.45
1.1
1.2
—
—
—
0
0
(3013512) EKG study
38
327
1.20
0.41
3.0
3.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
33
1.53
0.41
1.2
1.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
3.7
—
58.0
—
0
16
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
8
60
1.35
0.41
1.3
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
34
1.48
0.40
6.6
3.5
%
57.0
57.4
—
5
34
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.0
2.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
34
1.48
0.40
4.8
3.4
e9/l
4.0
4.5
—
5
34
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
144
1383
1.19
0.39
4.0
3.7
mmol/l
5.7
5.7
0.04
133
1270
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
3.6
—
0
6
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
168
0.76
0.37
1.8
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
17
135
1.29
0.37
1.4
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
41
1.48
0.36
1.5
1.3
—
—
—
0
0
(4034850)
6
43
1.41
0.35
20.8
8.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
132
1264
1.15
0.35
4.7
4.5
mmol/mol
39.1
38.5
0.27
122
1186
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
23
193
1.22
0.32
1.4
1.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
48
432
1.15
0.32
1.3
1.3
u/ml
0.4
1.0
2.02
12
122
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
7
52
1.36
0.31
2.7
3.2
%
91.0
92.6
—
7
52
(3014576) Chloride [Moles/volume] in Serum or Plasma
17
139
1.25
0.30
12.1
8.2
mmol/l
104.7
104.0
0.35
17
134
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
172
0.80
0.28
1.1
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
272
1.17
0.28
1.7
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
16
132
1.23
0.26
1.3
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
17
143
1.21
0.24
1.6
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
13
106
1.24
0.24
2.3
3.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
37
1.36
0.23
1.0
1.0
—
3.3
—
0
8
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
11
88
1.27
0.23
1.3
1.3
—
16.7
—
0
5
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
95
0.73
0.23
1.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
95
0.73
0.23
1.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
95
0.73
0.23
1.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
95
0.73
0.23
1.0
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
40
1.26
0.22
1.0
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
36
326
1.13
0.22
2.1
2.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
107
1.23
0.22
1.2
1.3
—
—
—
0
0
(3020891) Body temperature
5
42
1.20
0.21
11.4
5.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(4146454)
0
11
0.00
0.21
0.0
3.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
10
0.00
0.21
0.0
5.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(44790049)
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(44806118)
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
12
0.00
0.21
0.0
3.7
—
—
—
0
0
(44790047)
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(44790048)
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
43
1.17
0.21
1.8
4.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
48
1.26
0.20
1.3
2.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
41
379
1.11
0.18
1.6
1.4
g/l
2.2
2.1
0.04
26
242
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
60
1.17
0.18
2.4
2.1
u/l
36.7
37.5
—
7
53
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
39
360
1.11
0.18
1.5
1.6
mmol/l
1.5
1.4
0.17
31
308
(3015736) pH of Urine
63
597
1.08
0.17
3.0
3.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
141
1379
1.09
0.17
6.4
4.4
mu/l
1.8
1.8
0.10
130
1273
(40761511) CBC panel - Blood by Automated count
163
1605
1.13
0.16
14.3
10.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
77
0.77
0.16
1.5
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
78
0.76
0.16
1.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
78
0.76
0.16
1.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
6
80
0.74
0.15
1.3
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
79
1.15
0.15
2.8
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
86
0.81
0.15
2.0
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
41
385
1.08
0.13
2.2
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
19
171
1.12
0.13
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
126
0.86
0.11
1.2
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
17
153
1.12
0.11
1.2
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
28
261
1.09
0.10
1.8
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
29
309
0.93
0.10
1.7
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
46
1.09
0.09
1.4
2.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
13
116
1.13
0.09
3.0
2.3
g/l
11.7
10.5
0.54
13
106
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
38
399
0.94
0.09
1.5
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
56
1.07
0.09
1.0
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
57
1.05
0.08
15.5
17.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
62
0.80
0.08
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
65
1.08
0.08
1.4
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
174
0.91
0.08
1.6
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
137
1.10
0.07
2.9
3.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
78
1.03
0.07
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
80
0.87
0.07
1.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
101
0.89
0.06
1.4
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
102
0.88
0.06
1.1
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
104
0.86
0.06
1.0
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
141
0.92
0.05
4.7
6.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
60
585
1.04
0.05
2.0
2.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
74
726
1.03
0.04
3.1
2.6
ug/l
82.0
86.0
0.09
69
675
(3003694) ABO and Rh group [Type] in Blood
47
481
0.97
0.03
1.4
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
50
490
1.03
0.03
2.2
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13
122
1.07
0.03
4.3
3.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
29
299
0.96
0.02
3.4
3.1
mg/l
35.5
76.3
0.88
22
195
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
23
238
0.96
0.02
4.7
3.9
%
20.4
21.2
—
9
87
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
142
1413
1.02
0.01
3.9
3.7
mmol/l
4.7
4.7
0.01
134
1322
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
135
1357
0.98
0.01
3.6
3.4
mmol/l
1.4
1.3
0.61
126
1267
(3016502) Oxygen saturation in Arterial blood
10
106
0.94
0.01
11.6
13.7
%
93.6
96.6
—
10
101
(3009542) Hematocrit [Volume Fraction] of Blood
150
1494
1.02
0.00
16.2
11.9
%
40.6
40.7
0.04
125
1198
(40760892) CBC W Ordered Manual Differential panel - Blood
39
394
0.99
0.00
6.4
4.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
10
103
0.97
0.00
3.9
3.8
mmol/l
1.2
1.2
—
10
89
(3020682) Albumin/Creatinine [Ratio] in Urine
32
317
1.01
0.00
3.9
3.7
mg/mmol
7.0
10.8
0.37
24
205
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
19
185
1.03
0.00
2.6
2.7
ug/l
0.6
0.7
—
10
94
(3028026) IgM [Mass/volume] in Serum or Plasma
10
98
1.02
0.00
2.2
1.6
g/l
1.5
1.2
—
10
89
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
39.4
—
0
5
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1536.8
—
0
5
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
21.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
6.6
—
0
5
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.8
—
7.8
—
0
5
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
59
0.84
0.00
1.0
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
10.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
8
0.00
0.00
0.0
18.1
—
103.3
—
0
8
(3044927) Protein electrophoresis panel - Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
6
0.00
0.00
0.0
1.0
—
161.8
—
0
6
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.0
—
686.9
—
0
8
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
141
1410
1.00
0.00
3.8
3.6
mmol/l
1.4
1.5
0.83
131
1314
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
12.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
264.2
—
0
9
(3035320) C reactive protein [Mass/volume] in Body fluid
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
51.0
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_SUPERF_INJURY_ANKLE_FOOT_UNSPE – Superficial injury of ankle and foot, unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).